##gff-version 3
##sequence-region O00116 1 658
O00116	UniProtKB	Transit peptide	1	58	.	.	.	Note=Peroxisome;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O00116	UniProtKB	Chain	59	658	.	.	.	ID=PRO_0000020431;Note=Alkyldihydroxyacetonephosphate synthase%2C peroxisomal	
O00116	UniProtKB	Domain	202	384	.	.	.	Note=FAD-binding PCMH-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00718	
O00116	UniProtKB	Nucleotide binding	234	240	.	.	.	Note=FAD;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O00116	UniProtKB	Nucleotide binding	303	309	.	.	.	Note=FAD;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O00116	UniProtKB	Nucleotide binding	316	319	.	.	.	Note=FAD;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O00116	UniProtKB	Nucleotide binding	368	374	.	.	.	Note=FAD;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O00116	UniProtKB	Region	615	617	.	.	.	Note=Important for enzyme activity;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O00116	UniProtKB	Compositional bias	2	8	.	.	.	Note=Poly-Ala	
O00116	UniProtKB	Active site	578	578	.	.	.	Note=Proton donor/acceptor;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O00116	UniProtKB	Binding site	515	515	.	.	.	Note=Substrate;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O00116	UniProtKB	Site	419	419	.	.	.	Note=Important for enzyme activity;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O00116	UniProtKB	Modified residue	65	65	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
O00116	UniProtKB	Modified residue	74	74	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
O00116	UniProtKB	Modified residue	102	102	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
O00116	UniProtKB	Modified residue	347	347	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
O00116	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_066929;Note=In RCDP3%3B severely reduced protein levels. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21990100;Dbxref=PMID:21990100	
O00116	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_025895;Note=In RCDP3. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11152660;Dbxref=dbSNP:rs121434412,PMID:11152660	
O00116	UniProtKB	Natural variant	419	419	.	.	.	ID=VAR_005002;Note=In RCDP3. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9553082;Dbxref=dbSNP:rs121434411,PMID:9553082	
O00116	UniProtKB	Natural variant	469	469	.	.	.	ID=VAR_025896;Note=In RCDP3. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11152660;Dbxref=dbSNP:rs121434413,PMID:11152660	
O00116	UniProtKB	Natural variant	471	471	.	.	.	ID=VAR_066930;Note=In RCDP3%3B severely reduced protein levels. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21990100;Dbxref=PMID:21990100	
O00116	UniProtKB	Natural variant	568	568	.	.	.	ID=VAR_066931;Note=In RCDP3%3B does not affect protein levels. T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21990100;Dbxref=dbSNP:rs387907214,PMID:21990100	
